Sj. Judd et al., THE EFFECT OF ALPRAZOLAM ON SERUM CORTISOL AND LUTEINIZING-HORMONE PULSATILITY IN NORMAL WOMEN AND IN WOMEN WITH STRESS-RELATED ANOVULATION, The Journal of clinical endocrinology and metabolism, 80(3), 1995, pp. 818-823
Alprazolam, a benzodiazepine derivative, stimulates specific gamma-ami
nobutyric acid(A) receptors and has been found to inhibit CRH activity
in the brain. This study examined the effect of alprazolam on serum c
ortisol and LH pulsatility in six women in the early follicular phase
(EFP), six women in the midluteal phase (MLP), and six women with stre
ss-related anovulation (SRA) of normal weight, but with a previous his
tory of anorexia nervosa. Subjects were given alprazolam (2 mg, orally
) or an identical placebo capsule at 0900 h, and blood samples were co
llected through an indwelling venous catheter every 10 min for 8 h in
the SRA women and 10 h in EFP and MLP women. Women with SRA were also
given clomiphene (100 mg/day) for 5 days before a further 8-h blood sa
mpling session. As expected, there was a diurnal decline in serum leve
ls of cortisol, which was significantly less in women with SRA (55 +/-
4%) than those in both EFP (76 +/- 4%) and MLP women (75 +/- 3%; P <
0.005). The food-related rise of cortisol that follows lunch in normal
women was absent in women with SRA. Alprazolam accentuated the declin
e in serum cortisol, and in all three groups, the mean serum cortisol
level after alprazolam treatment was significantly less (P < 0.05) tha
n that after placebo.